Stay updated on Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.

Latest updates to the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and an explicit recruitment status line ('No longer looking for participants'), and standardizes the Intervention/Treatment label while updating the page revision tag to v3.6.0.SummaryDifference0.5%

- Check20 days agoChange DetectedThe revision stamp on the page was updated from v3.5.4 to v3.5.5, signaling a new release of the page framework. No study details or visible content were changed.SummaryDifference0.1%

- Check41 days agoChange DetectedRevision: v3.5.4 was added, replacing the previous Revision: v3.5.3, indicating a minor update to the study record on the page.SummaryDifference0.1%

- Check55 days agoChange DetectedNo additions or deletions are detected in the supplied change data for this study page.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page footer software revision was updated from **v3.5.2** to **v3.5.3**.SummaryDifference0.1%

- Check70 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Newly Diagnosed Glioblastoma Clinical Trial page.